Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer.
Journal: Head & neck
Published: February 24, 2026
Pituitary metastasis as the first sign of distant spread in mandibular squamous cell carcinoma.
Journal: Journal of surgical case reports
Published: February 23, 2026
Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma.
Journal: The Laryngoscope
Published: November 20, 2025
Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic Carcinoma.
Journal: Molecular cancer therapeutics
Published: November 04, 2025
Potent anti-tumor activity of the AXL-targeted antibody-drug conjugate, mipasetamab uzoptirine (ADCT-601), in preclinical models of adenoid cystic carcinoma.
Journal: Molecular cancer therapeutics
Published: November 04, 2025
Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: October 31, 2025
Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With Pembrolizumab.
Journal: Head & neck
Published: October 29, 2025
Timely Matters: Predictors of Delay in Oral Cavity Cancer Patients Across the Care Continuum.
Journal: Laryngoscope investigative otolaryngology
Published: September 09, 2025
A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells.
Journal: Cancer research
Published: August 19, 2025
A Patient With Prior Skin Cancers and New Diagnosis of Bell Palsy.
Journal: JAMA oncology
Published: August 07, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma.
Journal: Scientific reports
Published: March 15, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.
Journal: The lancet. Diabetes & endocrinology
Published: November 24, 2024
Last Updated: 09/26/2026